Gail Boudreaux bought $2.4M of ELV
President and CEO at Elevance Health, Inc.. 8,500 shares at an average of $286.94, traded Jul 18, 2025, filed Jul 18, 2025.
Score components
- +25RoleCEO
- +25Trade size$2.4M at market
- +3Relative to holdingsHoldings up 6%
- +18Price context0% above the 52-week low; 49% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001287920-25-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 18, 2025 | POpen-market purchase Common Stock | +2,334 | $286.07 | $668k | 144,854 | Jul 18, 2025 |
| Jul 18, 2025 | POpen-market purchase Common Stock | +5,116 | $287.12 | $1.5M | 149,970 | Jul 18, 2025 |
| Jul 18, 2025 | POpen-market purchase Common Stock | +1,050 | $287.96 | $302k | 151,020 | Jul 18, 2025 |
Related signals
Other insiders at Elevance Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | ELVbuy Elevance Health, Inc. | Susan D. DeVore director | $375k 1,200 shares | +52% | |
| 52Moderate | ELVsell Elevance Health, Inc. | Mark Kaye EVP & CFO | $1.9M 4,588 shares | -19% | |
| 40Moderate | Elevance Health, Inc. | Ronald W Penczek CAO & Controller | $184k 443 shares | -19% | |
| 58Moderate | Elevance Health, Inc. | Charles Morgan Kendrick JR EVP & President, Commercial | $1.4M 3,504 shares | -26% | |
| 50Moderate | ELVsell Elevance Health, Inc. | Charles Morgan Kendrick JR EVP & President, Commercial | $3.2M 7,417 shares | -47% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.